Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4355965 | 0.72 | NNMT (0.38) | LMNAALDH1A1L3MBTL1 | |
| SCHEMBL31387736 | 0.70 | CXCL8 (0.39) | CXCL8EPHX1APP | |
| SCHEMBL16150316 | 0.69 | HSD17B10 (0.50) | CXCL8EPHX1APPCYP2C9CYP2C19 | |
| SCHEMBL15698348 | 0.67 | LMNA (0.52) | LMNATP53CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL10771021 | 0.67 | HSD17B10 (0.59) | LMNATP53CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL17513421 | 0.67 | CXCL8 (0.60) | CXCL8LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL7820665 | 0.67 | LMNA (0.58) | CXCL8LMNAEPHX1APPTP53 | |
| SCHEMBL31532309 | 0.66 | CD44 (0.44) | LMNATP53CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL2527588 | 0.66 | CD44 (0.44) | LMNATP53CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL1817192 | 0.66 | CXCL8 (0.64) | CXCL8LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8052785-B2 | Polymer containing image receiver sheet on support | FUJIFILM CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20080242542-A1 | INDANILINE DYE, THERMAL TRANSFER RECORDING INK SHEET, THERMAL TRANSFER RECORDING METHOD, COLOR TONER, INKJET INK, AND COLOR FILTER | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242542-A1 | INDANILINE DYE, THERMAL TRANSFER RECORDING INK SHEET, THERMAL TRANSFER RECORDING METHOD, COLOR TONER, INKJET INK, AND COLOR FILTER | INMT, TYR, IK | CXCL8 3980/4885LMNA 3650/4885EPHX1 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.